Marinus Pharmaceuticals (MRNS) PT Lowered to $0.50 at Baird
Tweet Send to a Friend
Baird analyst Brian Skorney lowered the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $0.50 (from $2.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
